- ‘Into the Dark: I’m Just F*cking with You’ is one of the series’ best 6 Months Ago
- Trump’s latest prop, a map of ISIS, gets memed Today 12:54 PM
- HBO sends fans on a global scavenger hunt for 6 Iron Thrones Today 11:51 AM
- The Awkward Family Photos game is Cards Against Humanity for meme lovers Today 11:50 AM
- London firefighters’ organization accuses ‘Peppa Pig’ of sexism Today 11:41 AM
- YouTuber accused of abusing her children to make kid-friendly content Today 11:20 AM
- Ari Fleischer’s Iraq War tweet isn’t going over well Today 10:54 AM
- Cop arrested for recording man’s genitals, forcing mentally ill man to twerk Today 10:37 AM
- MoviePass rebrands its unlimited plan, again Today 10:37 AM
- Former Alaska senator launches meme-filled 2020 primary campaign Today 10:17 AM
- The Shane Dawson cat controversy has resulted in these sex memes Today 10:06 AM
- Sarah Sanders mocks CNN reporter with ‘dear diary’ tweet Today 9:03 AM
- Know what you’re signing up for thanks to these dating site reviews Today 8:58 AM
- CBS All Access now offers a month for free—just in time for March Madness Today 8:39 AM
- The Apex Legends: season 1 battle pass is finally here—and there’s a lot to unpack Today 8:38 AM
It’s unclear if young blood even makes a difference.
A startup called Ambrosia Medical plans to open its first clinic in New York City later this year, and it has an unusual aim: to fill patient veins with blood from more youthful donors.
For $8,000, Ambrosia Medical patrons can undergo a procedure that gives them an infusion of young blood, according to Business Insider. The belief is that in doing this, it can help slow the aging process, giving new life to old organs. The idea has also been parodied on TV in the HBO show Silicon Valley.
Ambrosia Medical conducted a clinical trial in the U.S. in 2017 studying whether this theory is accurate, but the results of that trial haven’t been made public yet. Still, company founder Jesse Karmazin told Business Insider that the results so far have been “really positive.” Anecdotally, recipients felt like they had better sleep, focus, and memory following a transfusion of young blood, as well as improved muscle tone. Those claims are not yet backed up with data, though.
Since Ambrosia Medical is giving patents a blood transfusion (or a plasma transfusion, specifically), a procedure approved by the FDA, it doesn’t face a unique or difficult approval process before opening its doors. According to CDC data, more than 14.5 million blood transfusions take place each year, and typically, recipients don’t experience any ill effects. However, proof from clinical trials could help boost business, adoption, and interest in the idea of using young blood to rejuvenate the older body.
Thus far, David Cavalier, Ambrosia’s chief operating officer, says that Ambrosia Medical has had about 150 patients, 81 of which participated in its clinical trial. Recipients have ranged in age from 35 to 92, while blood donors range in age from 16 to 25.
Ambrosia Medical’s website, which went live last week, is sparse. It consists primarily of a list of addresses where interested parties can email for more information, or you can be added to a waitlist to undergo an $8,000 transfusion.
H/T Business Insider
Christina Bonnington is a tech reporter who specializes in consumer gadgets, apps, and the trends shaping the technology industry. Her work has also appeared in Gizmodo, Wired, Refinery29, Slate, Bicycling, and Outside Magazine. She is based in the San Francisco Bay Area and has a background in electrical engineering.